US · guidance
CMS Pub. 100-03, ch. 1, § 30.1.1
Biofeedback Therapy for the Treatment of Urinary
Incontinence
(Rev. 1, 10-03-03)
CIM 35-27.1
Biofeedback Therapy for the Treatment of Urinary Incontinence
This policy applies to biofeedback therapy rendered by a practitioner in an office or other
facility setting.
Biofeedback is covered for the treatment of stress and/or urge incontinence in cognitively
intact patients who have failed a documented trial of pelvic muscle exercise (PME)
training. Biofeedback is not a treatment, per se, but a tool to help patients learn how to
perform PME. Biofeedback-assisted PME incorporates the use of an electronic or
mechanical device to relay visual and/or auditory evidence of pelvic floor muscle tone, in
order to improve awareness of pelvic floor musculature and to assist patients in the
performance of PME.
A failed trial of PME training is defined as no clinically significant improvement in
urinary incontinence after completing four weeks of an ordered plan of pelvic muscle
exercises to increase periurethral muscle strength.
Contractors may decide whether or not to cover biofeedback as an initial treatment
modality.
Home use of biofeedback therapy is not covered.
History
(Rev. 1, 10-03-03)
Provenance
- Source
- cms.gov
- Retrieved
- 2026-08-25
- Edition
- iom-2026-08-25
- Content hash
1fbd5aa4821d3ca6b8a2720ea690475dd765e2d24f2f06089f1212b2459727b5
The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.
Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.